Toronto, Canada (PRWEB) October 18, 2012
Markets in Europe and North America are saturated with clinical trials; patient enrolment and retention is becoming more challenging than ever. Strategies such as adding extra study sites in one country, extending enrollment timelines and increasing site and patient initiatives might not cut it.
Instead, managers should consider additional markets – such as those based in Russia and Ukraine, explains Richard Koenig, Vice President of Operations of ClinStar.
In a special webinar hosted by Xtalks, Mr. Koenig will discuss the enormous value and practical considerations of including Russia and Ukraine in global clinical studies. Mr. Koenig will also examine the benefits of in risk management and contingency planning. Specifically, he will evaluate the critical elements required for a successful study transition plan, including: regulatory tasks, drug storage, clinical management and monitoring investigator payments.
For more information or to register go to: http://xtks.in/xto-541p
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Karen Lim (416) 977-6555 ext 227